Pegah Golabi (P Golabi)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 30

Top Topics

Human Immunodeficiency Virus

Top Venues

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

Hepatology communications

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver 44 (4) (2024)
Zobair M Younossi, Pegah Golabi, James Paik, Soroor Owrangi, Yusuf Yilmaz, Mohamed El Kassas, Khaled A Alswat, Saleh A Alqahthani
Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver international : official journal of the International Association for the Study of the Liver (2024)
Pegah Golabi, Soroor Owrangi, Zobair M Younossi
Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Alimentary pharmacology & therapeutics (2024)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) (2023)
Ali A Weinstein, Dung Ngo, Leyla de Avila, Jillian Kallman Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn H Gerber, Zobair M Younossi
Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease. Annals of medicine 55 (1) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) 77 (4) (2023)
Ali A Weinstein, Dung Ngo, Leyla de Avila, Jillian Kallman Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn H Gerber, Zobair M Younossi
Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease. Annals of medicine 55 (1) (2023)
Ali A Weinstein, Dung Ngo, Leyla de Avila, Jillian Kallman Price, Pegah Golabi, Patrick Austin, Carey Escheik, Lynn H Gerber, Zobair M Younossi
Association of physical activity and fine motor performance in individuals with type 2 diabetes mellitus and/or non-alcoholic fatty liver disease. Annals of medicine 55 (1) (2023)
Zobair M Younossi, Pegah Golabi, James M Paik, Austin Henry, Catherine Van Dongen, Linda Henry
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology (Baltimore, Md.) (2023)
Zobair M Younossi, James M Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader
The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005-2010 and 2017-2018. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Austin Henry, James M Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics (2022)
Catherine Van Dongen, James M Paik, Michael Harring, Youssef Younossi, Jillian K Price, Khaled Kabbara, Pegah Golabi, Zobair M Younossi
Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatology communications 6 (11) (2022)
James M Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi
The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. Hepatology communications 5 (5) (2021)
Pegah Golabi, James M Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M Younossi
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology communications 4 (8) (2020)
Omer Shahab, Mehmet Sayiner, James Paik, Sean Felix, Pegah Golabi, Zobair M Younossi
Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States. Hepatology communications 3 (3) (2019)
Rati Deshpande, Maria Stepanova, Pegah Golabi, Kimberly Brown, Zobair M Younossi
Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units. Journal of viral hepatitis 26 (11) (2019)
Leyla de Avila, Ali A Weinstein, J Michael Estep, Michael P Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi
Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 39 (9) (2019)
Omer Shahab, Rakesh Biswas, James Paik, Haley Bush, Pegah Golabi, Zobair M Younossi
Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatology communications 2 (10) (2018)
N Fukui, Pegah Golabi, M Otgonsuren, L de Avila, H Bush, Zobair M Younossi
Hospice care in Medicare patients with primary liver cancer: the impact on resource utilisation and mortality. Alimentary pharmacology & therapeutics 47 (5) (2018)